Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

alectinib 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Disease Resistance × Clear all
NCT04662996 2026-02-12

MiR_CPMRC

University Hospital, Tours

Phase NA Completed
33 enrolled
Genitourinary

Prostatic Neoplasms, Disease Resistance

NCT04708639 2021-02-02

MonAlec

Aarhus University Hospital

Unknown
40 enrolled
Thoracic

Lung Neoplasms, Disease Resistance

NCT03400865 2018-10-16

Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas

Ruijin Hospital

Phase NA Unknown
30 enrolled

Prolactinoma, Disease Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡